[Puget Sound Business Journal] $1,000-a-pill hepatitis C drug may be too costly for Medicaid insurers
By Atia Musazay May 14, 2014 A breakthrough drug now on the market… Read More
By Atia Musazay May 14, 2014 A breakthrough drug now on the market… Read More
By Robert Langreth May 7, 2014 The backlash over surging drug… Read More
By Andy Miller May 6, 2014 Probably the biggest ethical dilemma now… Read More
BY JAMES SUROWIECKI April 28 Issue Few people have done better in the… Read More
By Jason Millman April 28, 2014 The new hepatitis C drug Sovaldi is… Read More
By Bruce Jaspen April 28, 2014 Medicaid health insurance programs for… Read More
JUDY WOODRUFF April 23, 2014 Watch Story Here JUDY WOODRUFF: Now: Who… Read More
By Jay Hancock April 18, 2014 UnitedHealth Group spent $100 million on… Read More
April 18, 2014 Illinois prison inmates will now be able to get a new… Read More
By Caroline Humer April 17, 2014 UnitedHealth Group Inc… Read More
By Stephanie M. Lee Apr. 12, 2014 The nation may have finally met a drug it… Read More
By German Lopez Apr. 11, 2014 Once again, US drug prices are coming… Read More